Navidea Reports Publication of Study Examining Use of Tc99m Tilmanocept for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Melanoma and Oral Cancer in Australia

Press/Media

Period10 Aug 2022

Media coverage

1

Media coverage

  • TitleNavidea Reports Publication of Study Examining Use of Tc99m Tilmanocept for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Melanoma and Oral Cancer in Australia
    Media name/outletManufacturing Close-Up
    Country/TerritoryUnited States
    Date10/08/22
    PersonsAbdul Razak